February 15, 2019 | Childhood Cancer, ICCD, Infographic
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We’ve pulled together an infographic to show just what we mean with data c/o Cancer Research UK (CRUK) and a great initiative by Beads of Courage, Inc.
There’s still more to do, so show your support for a day when there is No More Pain and No More Loss for all children with cancer regardless of where they live in the world.


Company Details
Latest Content from Cuttsy + Cuttsy
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.
